PROC: Procaps Group SA Revenue Growth QoQ

Graphic logo of Procaps Group Corp (PROC)

Procaps Group S.A. (PROC) minimizes risks through contract manufacturing of softgels and broad distribution. This quarterly revenue growth chart on GURU.Markets shows that 7.20 is becoming the new value for this metric. This trend reflects a transition to seamless outsourcing to reduce costs, although geopolitical barriers and raw material supply chain vulnerabilities continue to pressure the issuer's operating results.

PROC (Procaps Group) Quarterly Sales Growth history from 07/04/2022 to 02/16/2025

Comprehensive metric breakdowns and analytics for Procaps Group (PROC)

- current quotes and average value forecast:
- market capitalization information:
Fundamental company analysis:Procaps Group S.A. - PROC
Mass-produced product of Procaps

Procaps Group S.A. maintains uninterrupted production through logistics diversification and strategic raw material reserves. This operational resilience is quantified via the percentage change in quarterly sales, which smooths out short-term volatility and reveals long-term business development trends, allowing investors to use the current level of quarterly revenue growth to determine the phase between stable scaling and the risk of stagnation.

Competing companies

HLN - Revenue Growth QoQ|Quarterly Revenue Growth Rate kenvue.com|Verona Pharma (VRNA) - Revenue Growth QoQ|Quarterly Revenue Growth Rate Jyong Biotech Limited (MENS)|LGND (Ligand Pharmaceuticals Incorporated) - Quarterly Revenue Growth|Quarterly Revenue Growth Rate Amneal Pharmaceuticals Inc AMRX|Quarterly Revenue Growth PRGO|Sales Change QoQ ALVO|Quarterly Revenue Growth LQDA (Liquidia Technologies)|Quarterly Revenue Growth Galapagos GLPG|ANI Pharmaceuticals Inc - Quarterly Revenue Growth|MNKD (MannKind Corp.) - Sales Growth QoQ|AMPH: Quarterly Revenue Growth|PCRX (Pacira BioSciences) - Revenue Growth QoQ|Revenue Growth QoQ ARS Pharmaceuticals Inc|Quarterly Sales Growth Theravance Biopharma, Inc. (TBPH)|Quarterly Sales Growth AQST (Aquestive Pharma)|SCPH - Quarterly Revenue Growth Rate|Quarterly Revenue Growth TECX (Tectonic Therapeutic, Inc.)|TNXP - Quarterly Sales Growth|China SXT Pharmaceuticals, Inc. - Quarterly Revenue Growth|EPRX - Quarterly Revenue Growth|BHST: Quarterly Revenue Growth|Quarterly Revenue Growth Rate eXoZymes Inc (EXOZ)|ORMP (oramed.com) - Quarterly Revenue Growth|Sales Growth QoQ ENTX (Entera Bio)|Revenue Growth QoQ MindWalk (HYFT)|Quarterly Revenue Growth ABVC BioPharma, Inc. (ABVC)|Revenue Growth QoQ Cumberland Corp CPIX|QNTM - Quarterly Sales Growth|FGEN - Revenue Growth QoQ|TELO - Quarterly Revenue Growth|Rani Therapeutics Inc (RANI) - Revenue Growth QoQ|Sales Growth QoQ SNYR|Revenue Growth QoQ Rallybio Corp|Revenue Growth QoQ LEXX|Quarterly Revenue Growth PULM|PTHL: Revenue Dynamics QoQ|Quarterly Revenue Growth APM (Aptorum Group Ltd)|LYRA - Quarterly Sales Growth|Impact BioMedical Inc - Quarterly Revenue Growth|Revenue Dynamics QoQ TNFA|YCBD (cbdmd.com) - Quarterly Sales Growth|painreform.com - Quarterly Revenue Increase|Quarterly Sales Growth CYTO|Revenue Growth QoQ LIPO|Revenue Growth QoQ optinose.com (OPTN)|PIRS (Pieris Pharma) - Quarterly Revenue Increase|Quarterly Revenue Growth PTPI (petrospharma.com)|Quarterly Revenue Increase QLI|ACELYRIN - Quarterly Revenue Growth|Quarterly Revenue Increase TFFP (TFF Pharmaceuticals Inc.)